Platelet function in lung cancer patients undergoing lobectomy.

Area of Science:

• Oncology
• Hematology
• Cardiovascular Medicine

Background:

• Arterial thromboembolic disease is a growing concern in cancer patients.
• Platelets play a crucial role in thromboembolic events, necessitating investigation in cancer settings.
• Lung cancer surgery presents a unique context to study platelet behavior.

Purpose of the Study:

• To investigate platelet aggregation in lung cancer patients undergoing surgery.
• To compare platelet aggregation between video-assisted thoracoscopic surgery (VATS) and thoracotomy procedures.
• To assess changes in platelet aggregation from pre-surgery to post-surgery.

Main Methods:

• Prospective study of 93 lung cancer patients (VATS and thoracotomy groups).
• Platelet aggregation analyzed using impedance aggregometry with ADP and collagen agonists.
• Comparison with 121 healthy individuals pre-surgery and serial measurements post-surgery.

Main Results:

• Pre-surgery: Significantly increased platelet aggregation in both VATS and thoracotomy patients compared to healthy controls.
• Pre-surgery: No significant difference in platelet aggregation between VATS and thoracotomy patients.
• Post-surgery (Day 1): VATS patients showed increased collagen-induced platelet aggregation compared to pre-surgery levels.
• Post-surgery (Day 2): Thoracotomy patients showed reduced platelet aggregation compared to pre-surgery levels.

Conclusions:

• Primary lung cancer is associated with significantly increased platelet aggregation even before surgery.
• Surgical approach (VATS vs. thoracotomy) does not significantly alter the pattern of platelet aggregation increase on postoperative day one.
• Platelet aggregation dynamics differ between VATS and thoracotomy patients in the early postoperative period.